Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A novel mouse model of lipotoxic cardiomyopathy
Hsiu-Chiang Chiu, Attila Kovacs, David A. Ford, Fong-Fu Hsu, Ricardo Garcia, Pilar Herrero, Jeffrey E. Saffitz, Jean E. Schaffer
Hsiu-Chiang Chiu, Attila Kovacs, David A. Ford, Fong-Fu Hsu, Ricardo Garcia, Pilar Herrero, Jeffrey E. Saffitz, Jean E. Schaffer
View: Text | PDF | Erratum
Article

A novel mouse model of lipotoxic cardiomyopathy

  • Text
  • PDF
Abstract

Inherited and acquired cardiomyopathies are associated with marked intracellular lipid accumulation in the heart. To test the hypothesis that mismatch between myocardial fatty acid uptake and utilization leads to the accumulation of cardiotoxic lipid species, and to establish a mouse model of metabolic cardiomyopathy, we generated transgenic mouse lines that overexpress long-chain acyl-CoA synthetase in the heart (MHC-ACS). This protein plays an important role in vectorial fatty acid transport across the plasma membrane. MHC-ACS mice demonstrate cardiac-restricted expression of the transgene and marked cardiac myocyte triglyceride accumulation. Lipid accumulation is associated with initial cardiac hypertrophy, followed by the development of left-ventricular dysfunction and premature death. Terminal deoxynucleotidyl transferase–mediated dUTP nick-end labeling staining and cytochrome c release in transgenic hearts suggest that cardiac myocyte death occurs, in part, by lipid-induced programmed cell death. Taken together, our data demonstrate that fatty acid uptake/utilization mismatch in the heart leads to accumulation of lipid species toxic to cardiac myocytes. This novel mouse model will provide insight into the role of perturbations in myocardial lipid metabolism in the pathogenesis of inherited and acquired forms of heart failure.

Authors

Hsiu-Chiang Chiu, Attila Kovacs, David A. Ford, Fong-Fu Hsu, Ricardo Garcia, Pilar Herrero, Jeffrey E. Saffitz, Jean E. Schaffer

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Evidence for lipoapoptosis in MHC-ACS hearts. (a–c) Cardiac ventricular ...
Evidence for lipoapoptosis in MHC-ACS hearts. (a–c) Cardiac ventricular tissues from a 18-day-old O7 transgenic mice (a and c) and from a nontransgenic control littermate (b) were fixed in formalin, embedded in paraffin, and sectioned. Tissues were stained for DNA fragmentation by a TUNEL protocol that stains apoptotic nuclei brown and allows visualization of myocyte striations. Double staining for α-sarcomeric actin was used to identify cardiomyocytes in c (myocyte cytoplasm blue). (d) Cardiac ventricular tissues from 21-day-old O7 transgenic mice and nontransgenic control littermates were flash-frozen, homogenized, and separated by differential density centrifugation to yield a membrane fraction (mitochondria) and soluble fraction (cytosol). Membrane protein (20 μg) and soluble protein (80 μg) were separated by SDS-PAGE and analyzed by Western blotting using an anti–cytochrome c (cyt c) Ab and an anti–cytochrome oxidase subunit IV (cyt ox IV) Ab. Bands were quantified using Molecular Analyst software, and relative units of expression are shown for wild-type (–) and transgenic (+) tissues. Data points are expressed as mean (minimum of four independent samples) ± SE. Nonpaired t test was used to compare groups (AP = 0.06, BP = 0.01, CP < 0.01). (e) Ceramide was measured in heart tissue from 18-day-old transgenic and wild-type animals using the diacylglycerol kinase assay and normalized for tissue weight. Data points are expressed as mean (minimum of five independent samples) ± SE. Statistical evaluation between groups was by Student’s t test (AP < 0.0005).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts